# Doubling the Maintenance Dose of Clopidogrel in Patients With High On-Clopidogrel Platelet Reactivity

> **NCT00638326** · PHASE3 · TERMINATED · sponsor: **University of Pecs** · enrollment: 500 (estimated)

## Conditions studied

- Stable Angina Pectoris
- Ad Hoc Percutaneous Coronary Intervention

## Interventions

- **DRUG:** clopidogrel
- **DRUG:** clopidogrel plus placebo

## Key facts

- **NCT ID:** NCT00638326
- **Lead sponsor:** University of Pecs
- **Sponsor class:** OTHER
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** TERMINATED
- **Start date:** 2008-03
- **Primary completion:** 2009-09
- **Final completion:** 2010-03
- **Target enrollment:** 500 (ESTIMATED)
- **Why stopped:** Greater differences between randomized patients than previously anticipated
- **Last updated:** 2010-03-23


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00638326

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00638326, "Doubling the Maintenance Dose of Clopidogrel in Patients With High On-Clopidogrel Platelet Reactivity". Retrieved via MORVS 2026-10-12 from https://api.morvs.ai/clinical/NCT00638326. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*